Cited by 966IL-33, ST2, and ILC PathwaysCytokine Signaling Pathways and InteractionsGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Open access

Carriere, Virginie, Roussel, Lucie, Ortega, Nathalie, Lacorre, Delphine-Armelle, Americh, Laure, Aguilar, Luc, Bouche, Gérard, Girard, Jean-Philippe·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0606854104PMC PMC1765450

Open this paper in CoChat — free account

Abstract

Recent studies indicate that IL-1α functions intracellularly in pathways independent of its cell surface receptors by translocating to the nucleus and regulating transcription. Similarly, the chromatin-associated protein HMGB1 acts as both a nuclear factor and a secreted proinflammatory cytokine. Here, we show that IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, is an endothelium-derived, chromatin-associated nuclear factor with transcriptional repressor properties. We found that IL-33 is identical to NF-HEV, a nuclear factor preferentially expressed in high endothelial venules (HEV), that we previously characterized. Accordingly, in situ hybridization demonstrated that endothelial cells constitute a major source of IL-33 mRNA in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease. Immunostaining with three distinct antisera, directed against the N-terminal part and IL-1-like C-terminal domain, revealed that IL-33 is a heterochromatin-associated nuclear factor in HEV endothelial cells in vivo . Association of IL-33 with heterochromatin was also observed in human and mouse cells under living conditions. In addition, colocalization of IL-33 with mitotic chromatin was noted. Nuclear localization, heterochromatin-association, and targeting to mitotic chromosomes were all found to be mediated by an evolutionarily conserved homeodomain-like helix–turn–helix motif within the IL-33 N-terminal part. Finally, IL-33 was found to possess transcriptional repressor properties, associated with the homeodomain-like helix–turn–helix motif. Together, these data suggest that, similarly to IL1α and HMGB1, IL-33 is a dual function protein that may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0606854104

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Brown, K., Guest, S. S., Smale, S., Hahm, K., Merkenschlager, M., & Fisher, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80472-9 · Cited by 824
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & TRAVERS, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 619
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587

Show all 38 references

Research works printed but not linked: 1

CA Dinarello Eur Cytokine Netw 11, 483–486 (2000).

Sorted by citations

Items 301–400 of 965

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension
Shao, D., Perros, F., Caramori, G., Meng, C., Dormuller, P., Chou, P.-C., Church, C., Papi, A. A., Casolari, P., Welsh, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.111 · Cited by 76
IL-33 Exerts Neuroprotective Effect in Mice Intracerebral Hemorrhage Model Through Suppressing Inflammation/Apoptotic/Autophagic Pathway
Gao, Y., Ma, L., Luo, C., Wang, T., Zhang, M., Xi Zhong, S. H. E. N., Meng, H., Ji, M., Wang, Z., Chen, X., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9947-6 · Cited by 76
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
Saranchova, I., Han, J. S., Huang, H., Fenninger, F., Choi, K. B., Munro, L., Pfeifer, C. G., Welch, I. D., Wyatt, A. W., Fazli, L., et al. (2016) · Scientific Reports · doi:10.1038/srep30555 · Cited by 74
Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression
Long, A., Dominguez, D., Qin, L., Chen, S., Fan, J., Zhang, M., Fang, D., Zhang, Y., Kuzel, T. M., & Zhang, B. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800173 · Cited by 74
Anti‐interleukin‐33 inhibits cigarette smoke‐induced lung inflammation in mice
Qiu, C., Li, Y., Li, M., Li, M., Liu, X., McSharry, C. P., & Xu, D. (2012) · Immunology · doi:10.1111/imm.12020 · Cited by 76
Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant
Hong, J., Bae, S., Jhun, H., Lee, S., Choi, J., Kang, T., Kwak, A., Hong, K., Kim, E., Jo, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219089 · Cited by 76
Role of Interleukin-33 in Innate-Type Immune Cells in Allergy
Nakae, S., Morita, H., Ohno, T., Arae, K., Matsumoto, K., & Saito, H. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0538 · Cited by 73
Laundry detergents and surfactants‐induced eosinophilic airway inflammation by increasing IL ‐33 expression and activating ILC2s
Saito, K., Orimo, K., Kubo, T., Tamari, M., Yamada, A., Motomura, K., Sugiyama, H., Matsuoka, R., Nagano, N., Hayashi, Y., et al. (2023) · Allergy · doi:10.1111/all.15762 · Cited by 77
Cytokine regulation of immune responses to Porphyromonas gingivalis
Taylor, J. J. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00344.x · Cited by 73
IL-1 Family Members IL-18 and IL-33 Upregulate the Inflammatory Potential of Differentiated Human Th1 and Th2 Cultures
Blom, L. H., & Poulsen, L. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103685 · Cited by 73
Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue HomeostasisPreprint
Nagasawa, M., Spits, H., & Ros, X. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030304 · Cited by 72
Roles of Cytokines in Alzheimer’s Disease
Chen, Z., Balachandran, Y. L., Chong, W. P., & Chan, K. W. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115803 · Cited by 75
Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells
Li, C., Maillet, I., Mackowiak, C., Viala, C., Padova, F. D., Li, M., Togbe, D., Quesniaux, V. F. J., Lai, Y., & Ryffel, B. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.90 · Cited by 71
Alarmin cytokines as central regulators of cutaneous immunity
Hasegawa, T., Oka, T., & Demehri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876515 · Cited by 70
IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor
Günther, S., Deredge, D. J., Bowers, A. L., Luchini, A., Bonsor, D. A., Beadenkopf, R., Liotta, L. A., Wintrode, P. L., & Sundberg, E. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.004 · Cited by 70
Nuocytes: expanding the innate cell repertoire in type-2 immunity
Barlow, J. L., & McKenzie, A. N. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311160 · Cited by 70
Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation
Takeda, T., Unno, H., Morita, H., Futamura, K., Emi-Sugie, M., Arae, K., Shoda, T., Okada, N., Igarashi, A., Inoue, E., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.01.032 · Cited by 70
ST2 and the ST2/IL-33 signalling pathway–biochemistry and pathophysiology in animal models and humans
Pusceddu, I., Dieplinger, B., & Mueller, T. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.05.023 · Cited by 69
Nuocytes and beyond: new insights into helminth expulsion
Neill, D. R., & McKenzie, A. N. J. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.001 · Cited by 70
The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases
Chen, Y., Yu, C., & Deng, W. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1645138 · Cited by 71
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Makaremi, S., Asgarzadeh, A., Kianfar, H., Mohammadnia, A., Asghariazar, V., & Safarzadeh, E. (2022) · Inflammation Research · doi:10.1007/s00011-022-01596-w · Cited by 68
IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects
Hasan, A., Al-Ghimlas, F., Warsame, S., Alhubail, A., Ahmad, R., Bennakhi, A., Alarouj, M., Behbehani, K., Dehbi, M., & Dermime, S. (2014) · BMC Immunology · doi:10.1186/1471-2172-15-19 · Cited by 68
The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells
Sundlisæter, E., Edelmann, R. J., Fosse, J. H., Sponheim, J., Küchler, A. M., Weiss, M., Udalova, I. A., Midwood, K. S., Kasprzycka, M., & Haraldsen, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.003 · Cited by 75
IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure
Ghali, R., Altara, R., Louch, W. E., Cataliotti, A., Mallat, Z., Kaplan, A., Zouein, F. A., & Booz, G. W. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11157 · Cited by 72
Group 2 Innate Lymphoid Cells in the Regulation of Immune Responses
Roediger, B., & Weninger, W. (2014) · Advances in immunology · doi:10.1016/bs.ai.2014.09.004 · Cited by 70
Evidence for a regulatory loop between IFN‐γ and IL‐33 in skin inflammation
Seltmann, J., Werfel, T., & Wittmann, M. (2012) · Experimental Dermatology · doi:10.1111/exd.12076 · Cited by 67
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
Sundnes, O., Pietka, W., Loos, T., Sponheim, J., Rankin, A. L., Pflanz, S., Bertelsen, V., Sitek, J. C., Fosse, J. H., Haraldsen, G., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.85 · Cited by 67
Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis
Lapérine, O., Cloître, A., Caillon, J., Huck, O., Bugueno, I. M., Pilet, P., Sourice, S., Tilly, E. L., Palmer, G., Davideau, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168080 · Cited by 66
Targeting the IL-1 family members in skin inflammation.
Jensen, L. E. (2010) · PubMed · Cited by 66
Quantitative phosphoproteomic analysis of IL‐33‐mediated signaling
Pinto, S. M., Nirujogi, R. S., Rojas, P. L., Patil, A. H., Manda, S. S., Subbannayya, Y., Roa, J. C., Chatterjee, A., Prasad, T. S. K., & Pandey, A. (2014) · PROTEOMICS · doi:10.1002/pmic.201400303 · Cited by 69
Synovial Fibroblasts Promote the Expression and Granule Accumulation of Tryptase via Interleukin-33 and Its Receptor ST-2 (IL1RL1)
Kaieda, S., Shin, K., Nigrovic, P. A., Seki, K., Lee, R. T., Stevens, R. L., & Lee, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114991 · Cited by 66
Pathophysiology of IL-33 and IL-17 in allergic disorders
Gupta, R. K., Gupta, K., & Dwivedi, P. D. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.09.005 · Cited by 66
Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation
Park, J. H., Ameri, A. H., Dempsey, K. E., Conrad, D. N., Kem, M., Mino-Kenudson, M. A., & Demehri, S. (2021) · The EMBO Journal · doi:10.15252/embj.2020106151 · Cited by 67
A GM-CSF/IL-33 Pathway Facilitates Allergic Airway Responses to Sub-Threshold House Dust Mite Exposure
Llop‐Guevara, A., Chu, D. K., Walker, T. D., Goncharova, S. I., Fattouh, R., Silver, J. S., Moore, C. L., Xie, J. L., O’Byrne, P. M., Coyle, A. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088714 · Cited by 64
IL ‐33 and HMGB 1 alarmins: sensors of cellular death and their involvement in liver pathology
Arshad, M. I., Piquet‐Pellorce, C., & Samson, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02802.x · Cited by 70
NKT cells are required to induce high IL‐33 expression in hepatocytes during ConA‐induced acute hepatitis
Arshad, M. I., Rauch, M., L’Helgoualc’h, A., Julia, V., Leite‐de‐Moraes, M., Lucas‐Clerc, C., Piquet‐Pellorce, C., & Samson, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041332 · Cited by 69
TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis
Arshad, M. I., Piquet‐Pellorce, C., L’Helgoualc’h, A., Rauch, M., Patrat-Delon, S., Ezan, F., Lucas‐Clerc, C., Nabti, S., Lehuen, A., Cubero, F. J., et al. (2012) · Hepatology · doi:10.1002/hep.25893 · Cited by 68
Self-citation
Understanding the Unfolded Protein Response in the Pathogenesis of Asthma
Pathinayake, P. S., Hsu, A., Waters, D. W., Hansbro, P. M., Wood, L. G., & Wark, P. A. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00175 · Cited by 63
Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis B
Wang, J., Cai, Y., Ji, H., Feng, J., Ayana, D. A., Niu, J., & Jiang, Y. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0109 · Cited by 64
IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling
Saïdi, S., Bouri, F., Lencel, P., Duplomb, L., Baud’huin, M., Delplace, S., Leterme, D., Miellot, F., Heymann, D., Hardouin, P., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.021 · Cited by 67
IL-33 regulates TNF-α dependent effects in synovial fibroblasts
Kunisch, E., Chakilam, S., Gandesiri, M., & Kinne, R. W. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.883 · Cited by 66
Contradictory Functions (Activation/Termination) of Neutrophil Proteinase 3 Enzyme (PR3) in Interleukin-33 Biological Activity
Bae, S., Kang, T., Hong, J., Lee, S., Choi, J., Jhun, H., Kwak, A., Hong, K., Kim, E., Jo, S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295055 · Cited by 67
Emerging role of interleukin-1 in cardiovascular diseases
Vicenová, B., Vopálenský, V., Burýšek, L., & Pospíšek, M. (2009) · Physiological Research · doi:10.33549/physiolres.931673 · Cited by 64
Altered Treg and cytokine responses in RSV-infected infants
Christiaansen, A. F., Syed, M. A., Eyck, P. P. T., Hartwig, S. M., Durairaj, L., Kamath, S., & Varga, S. M. (2016) · Pediatric Research · doi:10.1038/pr.2016.130 · Cited by 66
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
McEntee, C. P., Finlay, C. M., & Lavelle, E. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01266 · Cited by 63
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis
Ciccia, F., Alessandro, R., Rizzo, A. G., Raimondo, S., Giardina, A. R., Raiata, F., Boiardi, L., Cavazza, A., Guggino, G., Leo, G. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201309 · Cited by 65
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
Neumann, K., Schiller, B., & Tiegs, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092732 · Cited by 64
Interleukin-33 in Malignancies: Friends or Foes?
Shen, J., Liu, J., & Zhang, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03051 · Cited by 67
New drugs targeting Th2 lymphocytes in asthma
Caramori, G., Groneberg, D. A., Ito, K., Casolari, P., Adcock, I. M., & Papi, A. A. (2008) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-3-s1-s6 · Cited by 63
IL‐33 promotes DC development in BM culture by triggering GM‐CSF production
Mayuzumi, N., Matsushima, H., & Takashima, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939472 · Cited by 62
ST2 Negatively Regulates TLR2 Signaling, but Is Not Required for Bacterial Lipoprotein-Induced Tolerance
Liu, J., Buckley, J. M., Redmond, H. P., & Wang, J. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904127 · Cited by 63
Interleukin‐33 regulates tissue remodelling and inhibits angiogenesis in the eye
Theodoropoulou, S., Copland, D. A., Liu, J., Wu, J., Gardner, P. J., Ozaki, E., Doyle, S., Campbell, M. D., & Dick, A. D. (2016) · The Journal of Pathology · doi:10.1002/path.4816 · Cited by 62
Airway innate lymphoid cells in the induction and regulation of allergy
Doherty, T. A., & Broide, D. H. (2018) · Allergology International · doi:10.1016/j.alit.2018.11.001 · Cited by 62
T reg cell–intrinsic requirements for ST2 signaling in health and neuroinflammation
Hemmers, S., Schizas, M., & Rudensky, A. Y. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201234 · Cited by 63
Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking
Hayasaka, H., Taniguchi, K., Fukai, S., & Miyasaka, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01687.x · Cited by 61
Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation
Ramadan, A. M., & Paczesny, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00014 · Cited by 65
Nuclear Myosin II Regulates the Assembly of Preinitiation Complex for ICAM-1 Gene Transcription
Li, Q., & Sarna, S. K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.040 · Cited by 61
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters
Talabot‐Ayer, D., Calo, N., Vigne, S., Lamacchia, C., Gabay, C., & Palmer, G. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811425 · Cited by 63
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 59
In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis
Biton, J., Athari, S. K., Thiolat, A., Santinon, F., Lemeiter, D., Hervé, R., Delavallée, L., Levescot, A., Roga, S., Decker, P., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502124 · Cited by 59
Self-citation
Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer
Liu, J., Wang, C., Cheng, T.-Y., Rixiati, Y., Ji, C., Deng, M., Yao, S., Yuan, L., Zhao, Y., Shen, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.008 · Cited by 59
Hypoxia-Inducible Factor-1α and Interleukin 33 Form a Regulatory Circuit to Perpetuate the Inflammation in Rheumatoid Arthritis
Hu, F., Shi, L., Mu, R., Zhu, J., Li, Y., Ma, X., Li, C., Jia, R., Yang, D., Li, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072650 · Cited by 58
At the Bench: Understanding group 2 innate lymphoid cells in disease
Doherty, T. A. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5bt0814-374r · Cited by 58
Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity–emerging roles in obesity, intestinal inflammation, and cancer
Schwartz, C., O’Grady, K., Lavelle, E. C., & Fallon, P. G. (2016) · European Journal of Immunology · doi:10.1002/eji.201545780 · Cited by 63
IL-33 and Thymic Stromal Lymphopoietin in mast cell functions
Saluja, R., Zoltowska, A., Ketelaar, M. E., & Nilsson, G. P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.047 · Cited by 59
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions
Daniel, C., Sartory, N. A., Zahn, N., Schmidt, R., Geißlinger, G., Radeke, H. H., & Stein, J. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.026 · Cited by 58
IL‐33/ST2 as a potential target for tumor immunotherapy
Jiang, W., Lian, J., Yue, Y., & Zhang, Y. (2021) · European Journal of Immunology · doi:10.1002/eji.202149175 · Cited by 59
From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?
D’Acquisto, F., Μaione, F., & Pederzoli-Ribeil, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.015 · Cited by 57
Role of Interleukin 1 in Atopic Dermatitis
Abramovits, W., Bejarano, J. J. R., & Valdecantos, W. C. (2013) · Dermatologic Clinics · doi:10.1016/j.det.2013.04.008 · Cited by 57
Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway
Hsu, C., & Bryce, P. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201224 · Cited by 61
Upregulation of Interleukin-33 in obstructive renal injury
Chen, W., Chang, Y., Su, C., Tsai, T., Chen, S., Hsing, C., & Yang, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.010 · Cited by 57
Danger signals in trauma
Relja, B., Mörs, K., & Marzi, İ. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0962-3 · Cited by 57
IL-33 in obesity: where do we go from here?
de Oliveira, M. F. A., Talvani, A., & Rocha‐Vieira, E. (2019) · Inflammation Research · doi:10.1007/s00011-019-01214-2 · Cited by 57
The airway epithelium in asthma
Bonser, L. R., & Erle, D. J. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.05.001 · Cited by 59
IL-33: A Sheep in Wolf’s Clothing?
Gadina, M., & Jefferies, C. A. (2007) · Science s STKE · doi:10.1126/stke.3902007pe31 · Cited by 58
Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis
Li, C., Mu, R., Guo, J., Wu, X., Tu, X., Liu, X., Hu, F., Guo, S., Zhu, J., Xu, H., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4554 · Cited by 56
Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice
Chen, H.-Z., Sun, Y. T., Lai, L., Wu, H., Xiao, Y., Ming, B., Gao, M., Zou, H., Xiong, P., Xu, Y., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.019 · Cited by 55
Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice
Wu, H., Yang, S., Wu, X., Zhao, J., Zhao, J., Ning, Q., Xu, Y., & Xie, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.073 · Cited by 55
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
Toplak, N., Blazina, Š., & Avčin, T. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s114532 · Cited by 55
Expression of IL ‐33 and its epigenetic regulation in multiple sclerosis
Zhang, F., Tossberg, J. T., Spurlock, C. F., Yao, S., Aune, T. M., & Sriram, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.47 · Cited by 54
Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Factor
Kenswil, K. J. G., Jaramillo, A. C., Ping, Z., Chen, S., Hoogenboezem, R. M., Mylona, M., Adisty, M. N., Bindels, E. M. J., Bos, P. K., Stoop, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.070 · Cited by 54
House dust mite allergens induce interleukin 33 (IL-33) synthesis and release from keratinocytes via ATP-mediated extracellular signaling
Dai, X., Tohyama, M., Murakami, M., Shiraishi, K., Liu, S., Mori, H., Utsunomiya, R., Maeyama, K., & Sayama, K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165719 · Cited by 56
An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis
Zeng, F., Chen, H., Chen, L., Mao, J., Cai, S., Xiao, Y., Li, J., Shi, J., Li, B., Xu, Y. X., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.07.027 · Cited by 53
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
Sun, Y. T., Wen, Y., Wang, L., Wen, L., You, W., Wei, S., Mao, L., Wang, H., Chen, Z., & Yang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654626 · Cited by 55
Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C
Wang, J., Zhao, P., Guo, H., Sun, X., Jiang, Z., Xu, L., Feng, J., Niu, J., & Jiang, Y. (2012) · Mediators of Inflammation · doi:10.1155/2012/819636 · Cited by 53
Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway
Hussey, G. S., Dziki, J. L., Lee, Y. C., Bartolacci, J. G., Behun, M. N., Turnquist, H. R., & Badylak, S. F. (2019) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2019.01.001 · Cited by 53
Interleukin‐33 Levels in Gingival Crevicular Fluid, Saliva, or Plasma Do Not Differentiate Chronic Periodontitis
Buduneli, N., Özçaka, Ö., & Nalbantsoy, A. (2011) · Journal of Periodontology · doi:10.1902/jop.2011.110239 · Cited by 52
Mechanisms of cytokine secretion: A portfolio of distinct pathways allows flexibility in cytokine activity
Duitman, E. H., Orinska, Z., & Bulfone-Paus, S. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.010 · Cited by 52
Increased IL-33 in Synovial Fluid and Paired Serum Is Associated with Disease Activity and Autoantibodies in Rheumatoid Arthritis
Tang, S., Huang, H., Hu, F., Zhou, W., Guo, J., Jiang, H., Mu, R., & Li, Z. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/985301 · Cited by 52
Lineage−Sca1+c-Kit−CD25+ Cells Are IL-33–Responsive Type 2 Innate Cells in the Mouse Bone Marrow
Brickshawana, A., Shapiro, V. S., Kita, H., & Pease, L. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102242 · Cited by 54
Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study
Zeng, X., Zhu, Z., Gao, Q., Wang, Y., Yu, X., Zhou, B., & Xi, M. (2016) · Disease Markers · doi:10.1155/2016/9262919 · Cited by 52
The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin
Fanny, M., Nascimento, M., Baron, L., Schricke, C., Maillet, I., Akbal, M., Riteau, N., Bert, M. L., Quesniaux, V. F. J., Ryffel, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01476 · Cited by 53
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03810-0 · Cited by 55
BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients
Levescot, A., Flamant, S., Basbous, S., Jacomet, F., Féraud, O., Bourgeois, E. A., Bonnet, M., Giraud, C., Roy, L., Barra, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2797 · Cited by 55
Self-citation
Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent Cells
Pollheimer, J., Bodin, J., Sundnes, O., Edelmann, R. J., Skånland, S. S., Sponheim, J., Brox, M. J., Sundlisæter, E., Loos, T., Vatn, M., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253427 · Cited by 54
IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis
Travers, J., Rochman, M., Caldwell, J. M., Besse, J. A., Miracle, C. E., & Rothenberg, M. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-17541-5 · Cited by 51
Interleukin (IL)-33 and the IL-1 Family of Cytokines—Regulators of Inflammation and Tissue HomeostasisPreprint
Vasanthakumar, A., & Kallies, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028506 · Cited by 53
A Direct Inhibitor of HMGB1 Cytokine
Girard, J. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.001 · Cited by 50
Self-citation
The potential role of IL-33/ST2 signaling in fibrotic diseases
Gao, Q., Li, Y., & Li, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-012r · Cited by 50
Serum levels of IL-33 is increased in patients with ankylosing spondylitis
Han, G., Zeng, L.-W., Liang, C., Cheng, B.-L., Yu, B.-S., Li, H., Zeng, F. F., & Liu, S. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1843-x · Cited by 50

Authors: Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P.
Affiliations: *Laboratoire de Biologie Vasculaire, Equipe Labellisée “La Ligue 2006,” Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089, 205 Route de Narbonne, 31077 Toulouse, France; and
Centre National de la Recherche Scientifique (FR)
Endocube, Prologue Biotech, BP700, Rue Pierre et Marie Curie, 31319 Labège Cedex, France
Corresponding author: Girard, Jean-Philippe
ORCID: Roussel, Lucie
Aguilar, Luc
Girard, Jean-Philippe
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-02
Volume: 104
Issue: 1
Pages: 282-287
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0606854104
PMC: PMC1765450
OpenAlex: W2093396768
Cited by: 966
References: 38
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 49 · 2022: 50 · 2021: 51 · 2020: 47 · 2019: 51 · 2018: 58 · 2017: 55 · 2016: 64 · 2015: 70 · 2014: 52 · 2013: 56 · 2012: 72
FWCI: 12.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Association pour la Recherche sur le Cancer
Drug Applied Research Center, Tabriz University of Medical Sciences
Topics: Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: IL-33, ST2 receptor, heterochromatin, nuclear factors, transcriptional repressor, endothelial cells, high endothelial venules, rheumatoid arthritis, Crohn's disease, chronic inflammation, HMGB1
MeSH terms: Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Arthritis, Rheumatoid, Crohn Disease, HeLa Cells, Heterochromatin, Humans, Interleukins, Membrane Proteins, Mitosis, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, RNA, Messenger, 3T3 Cells, Conserved Sequence, Receptors, Interleukin, Nuclear Localization Signals, Amino Acid Motifs, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks